Vericel Profile

4.5
USD 0.15  3.23%
4.5Last Month High 6.0 
4.25Trading Day  High 4.63 

Vericel exotic insider transaction detected

Vericel Corporation insider trading alert for general transaction of stock option (right to buy) by Bartel Ronnda, Chief Scientific Officer, on August 29, 2017. This event was filed by Vericel Corp with SEC on 2010-09-03. Initial filing of beneficial ownership - SEC Form 3 [view details]   

Vericel Summary

Vericel Corporation (VCEL) is traded on Nasdaq Capital Markets in USA. It is located in MASSACHUSETTS, U.S.A and employs 190 people. Vericel Corporation was previously listed under the symbol ASTM. Vericel is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Small-Cap' category with current market capitalization of 150.99 M. Vericel Corporation has 32.82 M outstanding shares of which 1.81 M shares are at this time shorted by private and institutional investors with about 5.26 trading days to cover. Vericel Corporati currently holds about 14.04 M in cash with (22.27 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.43.
Check Vericel Probability Of Bankruptcy

Ownership Allocation (%)

Top Holders

Selected Vericel Corporation Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Vericel Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
< 94% 
Vericel Corporationration, a commercialstage biopharmaceutical company, researches, develops, manufactures, markets, and sells patientspecific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameVericel Corporation
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock Stocks Directory
LocationMASSACHUSETTS, U.S.A
Business AddressCambridge, MA
ExchangeNasdaq Capital Markets
CUSIP92346J108
Prior SymbolASTM
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.aastrom.com
Contact Number617 588 5555
CurrencyUSD - US Dollar

Recommendations

Vericel Analyst Recommendations
Target PriceAdvice# of Analysts
8.87Buy3Odds
Vericel Corporation current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Vericel Analyst Advice  

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Earnings

Vericel Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.22March 13, 2017
Vericel Corporation normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate